Laboratoire Pediact - Octopus Pharma c Biogaia AB - Biogaia France - Tribunal des Activites Economiques de Paris Republique Francaise RG 2025035744 - French - 4 June 2026

Country
Year

2026

Summary

Le 14/08/2025, BIOGAIA AB a saisi la chambre de commerce internationale de Stockholm (ICC) pour régler par arbitrage le litige existant entre elle et PEDIACT concernant la résiliation du contrat et le règlement de factures. Cette procédure No 29737/ICA3 est pendante, la décision du tribunal arbitral devant être rendue au plus tard le 19/12/2026.

To download this document you need to be a subscriber

Sign in

Forgot password?

Sign in

Subscribe

Fill in the registration form and answer a few simple questions to receive a quote.

Subscribe now

Documents missing? Documents to share? Let us know!

If you know of documents which are currently missing from our Legal & Regulatory database do let us know. You can send them directly to us for inclusion in the database, anonymously or otherwise.
Learn more here